Hangzhou AGS MedTech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,425	4,733	4,810	7,223	-	-
Market Cap Growth	-10.06%	-1.60%	-33.41%	-	-	-
Enterprise Value	2,481	2,994	2,723	5,252	-	-
Last Close Price	54.56	58.63	58.43	85.62	-	-
PE Ratio	19.73	21.35	16.39	33.25	-	-
Forward PE	-	13.09	15.01	-	-	-
PS Ratio	7.31	7.97	7.56	14.20	-	-
PB Ratio	1.72	1.88	2.01	3.27	-	-
P/TBV Ratio	1.75	1.92	2.02	3.30	-	-
P/FCF Ratio	33.39	53.94	18.07	42.52	-	-
P/OCF Ratio	21.92	31.30	15.23	32.62	-	-
EV/Sales Ratio	4.10	5.04	4.28	10.32	-	-
EV/EBITDA Ratio	10.97	13.45	9.35	23.31	-	-
EV/EBIT Ratio	11.69	14.21	9.65	24.01	-	-
EV/FCF Ratio	18.72	34.13	10.23	30.92	-	-
Debt / Equity Ratio	0.01	0.02	0.00	0	0.00	0.01
Debt / EBITDA Ratio	0.14	0.17	0.01	0.00	0.01	0.02
Debt / FCF Ratio	0.24	0.43	0.01	0.00	0.02	0.02
Net Debt / Equity Ratio	-0.76	-0.77	-0.74	-0.92	-0.70	-0.75
Net Debt / EBITDA Ratio	-8.64	-8.66	-6.11	-9.04	-1.72	-1.68
Net Debt / FCF Ratio	-14.66	-21.98	-6.69	-11.99	-2.77	-1.98
Asset Turnover	0.23	0.23	0.26	0.36	0.91	1.01
Inventory Turnover	3.10	3.00	3.51	3.51	3.04	3.62
Quick Ratio	16.93	13.34	12.90	17.37	3.18	3.19
Current Ratio	17.49	13.79	13.34	17.78	3.65	3.81
Return on Equity (ROE)	8.83%	9.01%	12.74%	16.78%	44.40%	42.94%
Return on Assets (ROA)	5.05%	5.04%	7.22%	9.75%	23.02%	24.30%
Return on Invested Capital (ROIC)	29.41%	29.57%	61.13%	131.83%	143.69%	155.62%
Return on Capital Employed (ROCE)	8.20%	8.30%	11.70%	9.90%	39.30%	42.90%
Earnings Yield	5.02%	4.69%	6.10%	3.01%	-	-
FCF Yield	2.99%	1.85%	5.54%	2.35%	-	-
Dividend Yield	1.91%	1.77%	2.35%	1.21%	-	-
Payout Ratio	50.04%	50.15%	28.40%	20.25%	24.80%	46.80%
Buyback Yield / Dilution	0.35%	0.13%	-11.02%	-19.46%	0.00%	-
Total Shareholder Return	2.26%	1.90%	-8.67%	-18.25%	-	-